ARDELYX, INC. Related Party Transaction, Expenses from Transactions with Related Party
ARDELYX, INC. (ARDX) reported Related Party Transaction, Expenses from Transactions with Related Party of $58.00 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2014-11-07
- ARDELYX, INC. related party transaction, expenses from transactions with related party for the quarter ending 2014-09-30 was $58.00K, a 3.33% decline year-over-year.
- ARDELYX, INC. related party transaction, expenses from transactions with related party for the quarter ending 2014-06-30 was $60.00K, a 6.25% decline year-over-year.
- ARDELYX, INC. related party transaction, expenses from transactions with related party for the quarter ending 2013-09-30 was $60.00K.
- ARDELYX, INC. related party transaction, expenses from transactions with related party for the quarter ending 2013-06-30 was $64.00K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month |
|---|---|---|---|
| 2014-09-30 | $58.00K 10-Q · filed 2014-11-07 | $118.00K derived: sum of 2 quarters · filed 2014-11-07 | $190.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $60.00K 10-Q · filed 2014-08-08 | $120.00K 10-Q · filed 2014-08-08 | |
| 2013-09-30 | $60.00K 10-Q · filed 2014-11-07 | $124.00K derived: sum of 2 quarters · filed 2014-11-07 | $186.00K 10-Q · filed 2014-11-07 |
| 2013-06-30 | $64.00K 10-Q · filed 2014-08-08 | $126.00K 10-Q · filed 2014-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |